Based on 5 analysts giving stock ratings to MiMedx Group Inc in the past month.
In the current month, MDXG has received 5 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. MDXG average Analyst price target in the last month is 7.000.
Based on analysts' estimates, MDXG EPS is projected to reach -0.030 in FY2026Q4, following reported EPS of -0.060 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -0.06, while MiMedx Group IncMDXG's earnings per share (EPS) for the previous quarter was USD -0.10. EPS for the next quarter is expected at USD -0.03.